ACUITY INC. (DE) — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ACUITY INC. (DE) filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Aug 31, 2021 | $3.46B | Oct 27, 2021 |
| FY2021 | Aug 31, 2020 | $3.33B | Oct 27, 2021 |
| FY2021 | Aug 31, 2019 | $3.67B | Oct 27, 2021 |
| FY2018 | Aug 31, 2018 | $1.06B | Oct 25, 2018 |
| FY2018 | May 31, 2018 | $944.00M | Oct 25, 2018 |
| FY2018 | Feb 28, 2018 | $832.10M | Oct 25, 2018 |
| FY2018 | Nov 30, 2017 | $842.80M | Oct 25, 2018 |
| FY2018 | Aug 31, 2017 | $957.60M | Oct 25, 2018 |
| FY2018 | May 31, 2017 | $891.60M | Oct 25, 2018 |
| FY2018 | Feb 28, 2017 | $804.70M | Oct 25, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $4.35B | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $3.84B | Oct 27, 2025 |
| FY2025 | Aug 31, 2023 | $3.95B | Oct 27, 2025 |
| FY2024 | Aug 31, 2022 | $4.01B | Oct 28, 2024 |
| FY2023 | Aug 31, 2021 | $3.46B | Oct 26, 2023 |
| FY2020 | Aug 31, 2020 | $891.20M | Oct 23, 2020 |
| FY2020 | May 31, 2020 | $776.20M | Oct 23, 2020 |
| FY2020 | Feb 29, 2020 | $824.20M | Oct 23, 2020 |
| FY2020 | Nov 30, 2019 | $834.70M | Oct 23, 2020 |
| FY2020 | Aug 31, 2019 | $938.10M | Oct 23, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $2.08B | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $1.78B | Oct 27, 2025 |
| FY2025 | Aug 31, 2023 | $1.71B | Oct 27, 2025 |
| FY2024 | Aug 31, 2022 | $1.67B | Oct 28, 2024 |
| FY2023 | Aug 31, 2021 | $1.48B | Oct 26, 2023 |
| FY2020 | Aug 31, 2020 | $375.10M | Oct 23, 2020 |
| FY2020 | May 31, 2020 | $327.60M | Oct 23, 2020 |
| FY2020 | Feb 29, 2020 | $343.90M | Oct 23, 2020 |
| FY2020 | Nov 30, 2019 | $355.80M | Oct 23, 2020 |
| FY2020 | Aug 31, 2019 | $394.70M | Oct 23, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $396.60M | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $422.60M | Oct 27, 2025 |
| FY2025 | Aug 31, 2023 | $346.00M | Oct 27, 2025 |
| FY2024 | Aug 31, 2022 | $384.00M | Oct 28, 2024 |
| FY2023 | Aug 31, 2021 | $306.30M | Oct 26, 2023 |
| FY2020 | Aug 31, 2020 | $73.70M | Oct 23, 2020 |
| FY2020 | May 31, 2020 | $60.40M | Oct 23, 2020 |
| FY2020 | Feb 29, 2020 | $57.20M | Oct 23, 2020 |
| FY2020 | Nov 30, 2019 | $57.00M | Oct 23, 2020 |
| FY2020 | Aug 31, 2019 | $96.10M | Oct 23, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $563.90M | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $553.30M | Oct 27, 2025 |
| FY2025 | Aug 31, 2023 | $473.40M | Oct 27, 2025 |
| FY2024 | Aug 31, 2022 | $509.70M | Oct 28, 2024 |
| FY2023 | Aug 31, 2021 | $427.60M | Oct 26, 2023 |
| FY2022 | Aug 31, 2020 | $353.90M | Oct 26, 2022 |
| FY2021 | Aug 31, 2019 | $462.90M | Oct 27, 2021 |
| FY2020 | Aug 31, 2018 | $460.80M | Oct 23, 2020 |
| FY2019 | Aug 31, 2017 | $527.50M | Oct 29, 2019 |
| FY2018 | Aug 31, 2016 | $475.20M | Oct 25, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $140.20M | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $102.30M | Oct 27, 2025 |
| FY2025 | Aug 31, 2023 | $97.10M | Oct 27, 2025 |
| FY2024 | Aug 31, 2022 | $95.10M | Oct 28, 2024 |
| FY2023 | Aug 31, 2021 | $88.30M | Oct 26, 2023 |
| FY2022 | Aug 31, 2020 | $82.00M | Oct 26, 2022 |
| FY2021 | Aug 31, 2019 | $74.70M | Oct 27, 2021 |
| FY2020 | Aug 31, 2018 | $63.90M | Oct 23, 2020 |
| FY2019 | Aug 31, 2017 | $52.00M | Oct 29, 2019 |
| FY2018 | Aug 31, 2016 | $47.10M | Oct 25, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $1.48B | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $1.23B | Oct 27, 2025 |
| FY2025 | Aug 31, 2023 | $1.21B | Oct 27, 2025 |
| FY2024 | Aug 31, 2022 | $1.16B | Oct 28, 2024 |
| FY2023 | Aug 31, 2021 | $1.04B | Oct 26, 2023 |
| FY2022 | Aug 31, 2020 | $1.03B | Oct 26, 2022 |
| FY2021 | Aug 31, 2019 | $1.02B | Oct 27, 2021 |
| FY2020 | Aug 31, 2018 | $1.02B | Oct 23, 2020 |
| FY2019 | Aug 31, 2017 | $942.30M | Oct 29, 2019 |
| FY2018 | Aug 31, 2016 | $946.00M | Oct 25, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $601.40M | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $619.20M | Oct 27, 2025 |
| FY2025 | Aug 31, 2023 | $578.10M | Oct 27, 2025 |
| FY2024 | Aug 31, 2022 | $316.30M | Oct 28, 2024 |
| FY2023 | Aug 31, 2021 | $408.70M | Oct 26, 2023 |
| FY2022 | Aug 31, 2020 | $504.80M | Oct 26, 2022 |
| FY2021 | Aug 31, 2019 | $494.70M | Oct 27, 2021 |
| FY2020 | Aug 31, 2018 | $351.50M | Oct 23, 2020 |
| FY2019 | Aug 31, 2017 | $336.60M | Oct 29, 2019 |
| FY2018 | Aug 31, 2016 | $387.90M | Oct 25, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $68.40M | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $64.00M | Oct 27, 2025 |
| FY2025 | Aug 31, 2023 | $66.70M | Oct 27, 2025 |
| FY2024 | Aug 31, 2022 | $56.50M | Oct 28, 2024 |
| FY2023 | Aug 31, 2021 | $43.80M | Oct 26, 2023 |
| FY2022 | Aug 31, 2020 | $54.90M | Oct 26, 2022 |
| FY2021 | Aug 31, 2019 | $53.00M | Oct 27, 2021 |
| FY2020 | Aug 31, 2018 | $43.60M | Oct 23, 2020 |
| FY2019 | Aug 31, 2017 | $67.30M | Oct 29, 2019 |
| FY2018 | Aug 31, 2016 | $83.70M | Oct 25, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $4.76B | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $3.81B | Oct 27, 2025 |
| FY2025 | Aug 31, 2023 | $3.41B | Oct 27, 2025 |
| FY2024 | Aug 31, 2022 | $3.48B | Oct 28, 2024 |
| FY2023 | Aug 31, 2021 | $3.58B | Oct 26, 2023 |
| FY2021 | Aug 31, 2020 | $3.49B | Oct 27, 2021 |
| FY2020 | Aug 31, 2019 | $3.17B | Oct 23, 2020 |
| FY2019 | Aug 31, 2018 | $2.99B | Oct 29, 2019 |
| FY2018 | Aug 31, 2017 | $2.90B | Oct 25, 2018 |
| FY2017 | Aug 31, 2016 | $2.95B | Oct 26, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $2.03B | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $1.44B | Oct 27, 2025 |
| FY2024 | Aug 31, 2023 | $1.39B | Oct 28, 2024 |
| FY2023 | Aug 31, 2022 | $1.57B | Oct 26, 2023 |
| FY2022 | Aug 31, 2021 | $1.53B | Oct 26, 2022 |
| FY2021 | Aug 31, 2020 | $1.36B | Oct 27, 2021 |
| FY2020 | Aug 31, 2019 | $1.25B | Oct 23, 2020 |
| FY2019 | Aug 31, 2018 | $1.27B | Oct 29, 2019 |
| FY2018 | Aug 31, 2017 | $1.23B | Oct 25, 2018 |
| FY2017 | Aug 31, 2016 | $1.29B | Oct 26, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $2.72B | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $2.38B | Oct 27, 2025 |
| FY2025 | Aug 31, 2023 | $2.02B | Oct 27, 2025 |
| FY2025 | Aug 31, 2022 | $1.91B | Oct 27, 2025 |
| FY2024 | Aug 31, 2021 | $2.04B | Oct 28, 2024 |
| FY2023 | Aug 31, 2020 | $2.13B | Oct 26, 2023 |
| FY2022 | Aug 31, 2019 | $1.92B | Oct 26, 2022 |
| FY2021 | Aug 31, 2018 | $1.72B | Oct 27, 2021 |
| FY2020 | Aug 31, 2017 | $1.67B | Oct 23, 2020 |
| FY2019 | Aug 31, 2016 | $1.66B | Oct 29, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $1.50B | Oct 27, 2025 |
| FY2025 | Jun 1, 2025 | $1.50B | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $1.10B | Oct 27, 2025 |
| FY2024 | Jun 1, 2024 | $1.10B | Oct 28, 2024 |
| FY2025 | Aug 31, 2023 | $1.10B | Oct 27, 2025 |
| FY2024 | Aug 31, 2022 | $1.08B | Oct 28, 2024 |
| FY2023 | Aug 31, 2021 | $1.09B | Oct 26, 2023 |
| FY2022 | Aug 31, 2020 | $1.08B | Oct 26, 2022 |
| FY2021 | Aug 31, 2019 | $967.30M | Oct 27, 2021 |
| FY2020 | Aug 31, 2018 | $970.60M | Oct 23, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $4.29B | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $3.91B | Oct 27, 2025 |
| FY2024 | Aug 31, 2023 | $3.51B | Oct 28, 2024 |
| FY2023 | Aug 31, 2022 | $3.18B | Oct 26, 2023 |
| FY2022 | Aug 31, 2021 | $2.81B | Oct 26, 2022 |
| FY2021 | Aug 31, 2020 | $2.52B | Oct 27, 2021 |
| FY2020 | Aug 31, 2019 | $2.30B | Oct 23, 2020 |
| FY2019 | Aug 31, 2018 | $2.00B | Oct 29, 2019 |
| FY2018 | Aug 31, 2017 | $1.66B | Oct 25, 2018 |
| FY2017 | Aug 31, 2016 | $1.36B | Oct 26, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $422.50M | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $845.80M | Oct 27, 2025 |
| FY2024 | Aug 31, 2023 | $397.90M | Oct 28, 2024 |
| FY2023 | Aug 31, 2022 | $223.20M | Oct 26, 2023 |
| FY2022 | Aug 31, 2021 | $491.30M | Oct 26, 2022 |
| FY2021 | Aug 31, 2020 | $560.70M | Oct 27, 2021 |
| FY2020 | Aug 31, 2019 | $461.00M | Oct 23, 2020 |
| FY2019 | Aug 31, 2018 | $129.10M | Oct 29, 2019 |
| FY2018 | Aug 31, 2017 | $311.10M | Oct 25, 2018 |
| FY2018 | Aug 31, 2016 | $413.20M | Oct 25, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Aug 31, 2021 | $494.30M | Oct 27, 2021 |
| FY2021 | Aug 31, 2020 | $401.10M | Oct 27, 2021 |
| FY2020 | Aug 31, 2019 | $356.60M | Oct 23, 2020 |
| FY2019 | Aug 31, 2018 | $356.80M | Oct 29, 2019 |
| FY2018 | Aug 31, 2017 | $356.90M | Oct 25, 2018 |
| FY2017 | Aug 31, 2016 | $355.20M | Oct 26, 2017 |
| FY2016 | Aug 31, 2015 | $352.40M | Oct 27, 2016 |
| FY2015 | Aug 31, 2014 | $351.90M | Oct 27, 2015 |
| FY2014 | Aug 31, 2013 | $353.60M | Oct 29, 2014 |
| FY2013 | Aug 31, 2012 | $353.50M | Oct 29, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | 12 | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | 13 | Oct 27, 2025 |
| FY2025 | Aug 31, 2023 | 10 | Oct 27, 2025 |
| FY2024 | Aug 31, 2022 | 11 | Oct 28, 2024 |
| FY2023 | Aug 31, 2021 | 8 | Oct 26, 2023 |
| FY2020 | Aug 31, 2020 | 1 | Oct 23, 2020 |
| FY2020 | May 31, 2020 | 1 | Oct 23, 2020 |
| FY2020 | Feb 29, 2020 | 1 | Oct 23, 2020 |
| FY2020 | Nov 30, 2019 | 1 | Oct 23, 2020 |
| FY2020 | Aug 31, 2019 | 2 | Oct 23, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | 12 | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | 13 | Oct 27, 2025 |
| FY2025 | Aug 31, 2023 | 10 | Oct 27, 2025 |
| FY2024 | Aug 31, 2022 | 11 | Oct 28, 2024 |
| FY2023 | Aug 31, 2021 | 8 | Oct 26, 2023 |
| FY2020 | Aug 31, 2020 | 1 | Oct 23, 2020 |
| FY2020 | May 31, 2020 | 1 | Oct 23, 2020 |
| FY2020 | Feb 29, 2020 | 1 | Oct 23, 2020 |
| FY2020 | Nov 30, 2019 | 1 | Oct 23, 2020 |
| FY2020 | Aug 31, 2019 | 2 | Oct 23, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Aug 31, 2016 | 43.79M | Oct 27, 2016 |
| FY2016 | Aug 31, 2015 | 43.31M | Oct 27, 2016 |
| FY2015 | Aug 31, 2014 | 42.86M | Oct 27, 2015 |
| FY2014 | Aug 31, 2013 | 42.49M | Oct 29, 2014 |
| FY2013 | Aug 31, 2012 | 41.79M | Oct 29, 2013 |
| FY2012 | Aug 31, 2011 | 41.49M | Oct 26, 2012 |
| FY2011 | Aug 31, 2010 | 42.12M | Oct 28, 2011 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $20.60M | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $18.20M | Oct 27, 2025 |
| FY2025 | Aug 31, 2023 | $16.80M | Oct 27, 2025 |
| FY2024 | Aug 31, 2022 | $18.10M | Oct 28, 2024 |
| FY2023 | Aug 31, 2021 | $19.10M | Oct 26, 2023 |
| FY2022 | Aug 31, 2020 | $20.80M | Oct 26, 2022 |
| FY2021 | Aug 31, 2019 | $20.80M | Oct 27, 2021 |
| FY2020 | Aug 31, 2018 | $21.40M | Oct 23, 2020 |
| FY2019 | Aug 31, 2017 | $22.70M | Oct 29, 2019 |
| FY2018 | Aug 31, 2016 | $22.90M | Oct 25, 2018 |